Coronavirus
224
5
6
135
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
43 trials with published results (19%)
Research Maturity
135 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.8%
22 terminated out of 224 trials
86.0%
-0.6% vs benchmark
14%
31 trials in Phase 3/4
32%
43 of 135 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 135 completed trials
Clinical Trials (224)
A Study to Explore the Role of Gut Flora in COVID-19 Infection
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers
ELderly REspiratory VIral Cohort
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
SPI-1005 Treatment in Severe COVID-19 Patients
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2
COVID-19 Biorepository
Rutgers COVID-19 Cohort Study
A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19
Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
An Observational Study of Patients With Coronavirus Disease 2019
Inflammatory Signal Inhibitors for COVID-19 (MATIS)
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19